Synaptogenix Historical Financial Ratios
SNPX Stock | USD 2.72 0.01 0.37% |
Synaptogenix is promptly reporting on over 81 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 33.95, Invested Capital of 0.0, Average Payables of 1 M or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Synaptogenix financial condition quickly.
Synaptogenix |
About Synaptogenix Financial Ratios Analysis
SynaptogenixFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Synaptogenix investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Synaptogenix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Synaptogenix history.
Synaptogenix Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Synaptogenix dividend as a percentage of Synaptogenix stock price. Synaptogenix dividend yield is a measure of Synaptogenix stock productivity, which can be interpreted as interest rate earned on an Synaptogenix investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Synaptogenix's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Synaptogenix current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.At this time, Synaptogenix's Payables Turnover is fairly stable compared to the past year. EV To Operating Cash Flow is likely to rise to 5.17 in 2024, whereas PTB Ratio is likely to drop 0.12 in 2024.
2021 | 2023 | 2024 (projected) | PTB Ratio | 31.82 | 0.13 | 0.12 | Dividend Yield | 5.72E-4 | 0.2 | 0.21 |
Synaptogenix fundamentals Correlations
Click cells to compare fundamentals
Synaptogenix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Synaptogenix fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Ptb Ratio | 29.36 | 36.71 | 31.82 | 5.72 | 0.13 | 0.12 | |
Book Value Per Share | 2.93 | 4.09 | 6.69 | 5.07 | 54.89 | 33.95 | |
Free Cash Flow Yield | (0.0232) | (0.043) | (0.008167) | (0.0553) | (1.63) | (1.55) | |
Operating Cash Flow Per Share | (2.0) | (6.44) | (1.74) | (1.6) | (11.1) | (11.65) | |
Capex To Depreciation | 1.19 | 1.11 | 0.64 | 1.3 | 0.43 | 0.41 | |
Pb Ratio | 29.36 | 36.71 | 31.82 | 5.72 | 0.13 | 0.12 | |
Free Cash Flow Per Share | (2.0) | (6.45) | (1.74) | (1.61) | (11.11) | (11.66) | |
Roic | (0.87) | (2.06) | (0.38) | (0.73) | (0.34) | (0.36) | |
Net Income Per Share | (2.48) | (11.33) | (2.51) | (0.78) | (12.96) | (13.6) | |
Payables Turnover | 0.0106 | 0.003866 | 0.00383 | 0.008655 | 0.0143 | 0.015 | |
Cash Per Share | 2.92 | 4.61 | 6.82 | 5.36 | 64.58 | 37.69 | |
Pocfratio | (43.03) | (23.28) | (122.49) | (18.08) | (0.61) | (0.64) | |
Capex To Operating Cash Flow | (4.39E-4) | (6.68E-4) | (3.67E-4) | (6.61E-4) | (5.23E-4) | (5.49E-4) | |
Pfcf Ratio | (43.01) | (23.27) | (122.44) | (18.07) | (0.61) | (0.64) | |
Days Payables Outstanding | 34.4K | 94.4K | 95.3K | 42.2K | 25.6K | 24.3K | |
Income Quality | 0.79 | 0.64 | 0.69 | 2.01 | 0.86 | 0.76 | |
Roe | (0.85) | (2.77) | (0.38) | (0.15) | (0.25) | (0.26) | |
Ev To Operating Cash Flow | (41.57) | (22.57) | (118.56) | (14.74) | 4.93 | 5.17 | |
Pe Ratio | (34.66) | (13.24) | (84.65) | (37.14) | (0.52) | (0.55) | |
Return On Tangible Assets | (0.82) | (2.11) | (0.35) | (0.14) | (0.19) | (0.2) | |
Ev To Free Cash Flow | (41.55) | (22.55) | (118.52) | (14.73) | 4.93 | 5.17 | |
Earnings Yield | (0.0288) | (0.0755) | (0.0118) | (0.0269) | (1.91) | (1.81) | |
Net Debt To E B I T D A | 1.12 | 0.52 | 2.71 | 2.32 | 3.45 | 3.62 | |
Current Ratio | 37.32 | 4.17 | 17.8 | 29.39 | 7.14 | 6.78 | |
Tangible Book Value Per Share | 2.93 | 4.09 | 6.69 | 5.07 | 54.89 | 33.95 | |
Graham Number | 12.79 | 32.28 | 19.44 | 9.44 | 123.4 | 98.68 | |
Shareholders Equity Per Share | 2.93 | 4.09 | 6.69 | 5.07 | 52.24 | 33.45 | |
Capex Per Share | 8.77E-4 | 0.004304 | 6.38E-4 | 0.001061 | 0.005808 | 0.004782 | |
Graham Net Net | 2.84 | 3.4 | 6.42 | 4.91 | 52.72 | 32.85 | |
Enterprise Value Over E B I T D A | (31.86) | (16.4) | (81.88) | (10.24) | 3.07 | 3.22 | |
Price Earnings Ratio | (34.66) | (13.24) | (84.65) | (37.14) | (0.52) | (0.55) | |
Price Book Value Ratio | 29.36 | 36.71 | 31.82 | 5.72 | 0.13 | 0.12 | |
Days Of Payables Outstanding | 34.4K | 94.4K | 95.3K | 42.2K | 25.6K | 24.3K | |
Price To Operating Cash Flows Ratio | (43.03) | (23.28) | (122.49) | (18.08) | (0.61) | (0.64) | |
Price To Free Cash Flows Ratio | (43.01) | (23.27) | (122.44) | (18.07) | (0.61) | (0.64) | |
Ebt Per Ebit | 0.98 | 1.34 | 1.0 | 0.21 | 0.73 | 0.96 | |
Effective Tax Rate | 0.025 | (0.12) | 5.64E-4 | 0.0208 | 0.0187 | 0.0196 | |
Company Equity Multiplier | 1.03 | 1.31 | 1.06 | 1.09 | 1.28 | 0.92 | |
Return On Capital Employed | (0.89) | (1.84) | (0.38) | (0.71) | (0.31) | (0.33) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Synaptogenix Stock Analysis
When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.